Abouchedid, R., Gilks, T., Dargan, P. I., Archer, J. R. H., & Wood, D. M. (2018). Assessment of the Availability, Cost, and Motivations for Use over Time of the New Psychoactive Substances—Benzodiazepines Diclazepam, Flubromazepam, and Pyrazolam—in the UK. J Med Toxicol.

Abouchedid, Rachelle, Thea Gilks, Paul I. Dargan, John R. H. Archer, and David M. Wood. "Assessment of the Availability, Cost, and Motivations for Use Over Time of the New Psychoactive Substances—Benzodiazepines Diclazepam, Flubromazepam, and Pyrazolam—in the UK." J Med Toxicol 2018.

Abouchedid, Rachelle, et al. "Assessment of the Availability, Cost, and Motivations for Use Over Time of the New Psychoactive Substances—Benzodiazepines Diclazepam, Flubromazepam, and Pyrazolam—in the UK." J Med Toxicol 2018.